Johnson & Johnson (NYSE: JNJ) saw revenue and earnings decline for the second quarter of 2020 but both the top and bottom
Johnson & Johnson (JNJ): Postponement of procedures hits medical devices unit hard in Q2
Categories
pharmaceuticals
Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement
Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today. Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell
Biocept (BIOC) – Is it worth buying?
Investing in microcap stocks are considered to be risky; even higher so in uncertain market environments like the one we are seeing
Rite Aid Corp (NYSE: RAD) Q1 2021 Earnings Call Transcript
Rite Aid Corp (RAD) Q1 2021 earnings call dated June 25, 2020 Corporate Participants: Byron Purcell -- Treasurer & Investor Relations Heyward Donigan -- President and
Rite Aid (RAD) posts narrower-than-expected loss in Q1
Rite Aid Corporation (NYSE: RAD) reported a narrower loss in the first quarter of fiscal 2021 as an increase in the store
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Q1 2020 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (TEVA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Kevin C. Mannix -- Senior Vice President, Investor Relations
Dr.Reddy’s Laboratories Ltd. (NYSE: RDY) Q4 2020 Earnings Call Transcript
Dr.Reddy's Laboratories Ltd. (RDY) Q4 2020 earnings call dated May. 20, 2020 Corporate Participants: Amit Agarwal -- Investor Relations G V Prasad -- Co-Chairman and Managing
Moderna (MRNA) soars to a new 52-week high on positive phase 1 COVID-19 vaccine data
The entire world is waiting for some good news on a vaccine for the novel coronavirus. So far the global pandemic has
Palatin is looking for new collaborations amid AMAG’s divestiture of Vyleesi
When most of the companies were discussing how they got impacted by the deadly virus and the uncertainties they faced in the
Fueled by funding, Novavax (NVAX) gains ground in race for Covid-19 vaccine
For Novavax Inc. (NASDAQ: NVAX), the new fiscal year is of great significance due to the progress it has achieved in developing
INOVIO Pharmaceuticals expects results from initial trials for COVID-19 vaccine next month
INOVIO Pharmaceuticals (NASDAQ: INO), which is among the frontrunners in developing a vaccine for the coronavirus disease, said during its post-earnings conference
Mylan N.V. (NASDAQ: MYL) Q1 2020 Earnings Call Transcript
Mylan N.V. (MYL) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations Robert J. Coury -- Executive
AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) Q1 2020 Earnings Call Transcript
AMAG Pharmaceuticals Inc. (AMAG) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Linda Lennox -- Vice President of Investor Relations and Corporate
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q1 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc (EGRX) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Lisa Wilson -- Investor Relations Scott Tarriff -- Founder, Chief Executive Officer
Mylan (MYL) swings to a profit in Q1, reaffirms FY20 outlook
Mylan N.V. (NASDAQ: MYL) reported its financial results for the quarter ended March 31, 2020, on Monday before the market opens. The
Infographic: Highlights of Bausch Health (BHC) Q1 2020 earnings results
Bausch Health Companies Inc. (NYSE: BHC) reported a wider loss in the first quarter of 2020 due to lower income taxes benefit
Horizon Therapeutics PLC (NASDAQ: HZNP) Q1 2020 Earnings Call Transcript
Horizon Therapeutics PLC (HZNP) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Tina Ventura -- Senior Vice President, Investor Relations Tim Walbert -- Chairman,
Visual Representation of Bristol-Myers Squibb Company (BMY) Q1 2020 earnings
Bristol-Myers Squibb Company (NYSE: BMY) reported first-quarter 2020 financial results before the regular trading hours on Thursday. The results were better than
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results
Teva Pharmaceuticals' (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue
CVS Health (NYSE: CVS) Q1 2020 Earnings Call Transcript
CVS Health Corp. (CVS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President, Investor Relations Larry
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q1 2020 Earnings Call Transcript
Alexion Pharmaceuticals Inc (ALXN) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Chris Stevo -- Head of Investor Relations Ludwig Hantson -- Chief Executive